department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

bimatoprost CR · pharmadog

pharmadog
drugs
bimatoprost CR

drug · small molecule

patient view →

bimatoprost CR

Phase 3updated 2mo ago

by $SGP SpyGlass Pharma, Inc.🔗 ChEMBL

Phase 3

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 8 investigational indications.

targets

Prostaglandin F2-alpha receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

trade names

Bimatoprost, Bimatoprost component of ganfort, Durysta, Latisse, Lumigan

generic

bimatoprost

MOA

Prostanoid FP receptor agonist

indication

Ocular Hypertension

phase

phase_3

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 15m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

drugBIMATOPROST3 co-mentions · 3 sources
drugLumigan3 co-mentions · 3 sources
drugbimatoprost SR3 co-mentions · 3 sources
tagApproval2 co-mentions · 1 sources
tagRecall2 co-mentions · 2 sources

Trials studying bimatoprost CR

phase4Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Userecruitingn=20
phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)recruitingn=400
phase3Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)recruitingn=400
N/AEvaluation of the Safety and Effectiveness of the Bimatoprost Implant System / IOL Combination in Patients With Ocular Hypertension or Mild to Moderate Open-angle Glaucomacompletedn=24
phase3Long-term Safety and Efficacy Extension Trial of Bimatoprost SRactive not recruitingn=455
phase2Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solutionactive not recruitingn=201
phase3Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertensioncompletedn=515
phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)completedn=83

more trials →